AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by <i>rfaP</i> and <i>ybaT</i> deletion-Reference-Cited by-同舟云学术

AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by rfaP and ybaT deletion

Published:2024-07-29 Issue:1 Volume:16 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Leccese G.¹^ORCID,Chiara M.¹^ORCID,Dusetti I.¹^ORCID,Noviello D.²³^ORCID,Billard E.⁴^ORCID,Bibi A.¹,Conte G.¹,Consolandi C.⁵,Vecchi M.²³,Conte MP⁶^ORCID,Barnich N.⁴^ORCID,Caprioli F.²³^ORCID,Facciotti F.⁷^ORCID,Paroni M.¹^ORCID

Affiliation:

1. Department of Biosciences, Università degli Studi di Milano, Milan, Italy

2. Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

3. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

4. M2iSH, UMR 1071 Inserm, INRAe USC 1382, CRNH, University of Clermont Auvergne, Clermont-Ferrand, France

5. Institute of Biomedical Technologies, National Research Council (ITB-CNR), Segrate, Milan, Italy

6. Department of Public Health and Infectious Diseases, ‘Sapienza’ University of Rome, Rome, Italy

7. Department of Biotechnology and Bioscience, University of Milano-Bicocca, Milan, Italy

Funder

Cariplo Foundation-Biomedical Research

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2024.2380064

Reference70 articles.

1. Pathophysiology of Inflammatory Bowel Diseases

2. Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease

3. The current state of the art for biological therapies and new small molecules in inflammatory bowel disease

4. Targeting the microbiome in Crohn’s disease

5. Modulating the Microbiome for Crohn’s Disease Treatment